KCNH1

Chr 1AD

potassium voltage-gated channel subfamily H member 1

Also known as: EAG, EAG1, K(V)10.1, Kv10.1, TMBTS, ZLS1, h-eag, hEAG

Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Temple-Baraitser syndromeMIM #611816
AD
Zimmermann-Laband syndrome 1MIM #135500
AD
587
ClinVar variants
16
Pathogenic / LP
0.55
pLI score
0
Active trials
Clinical SummaryKCNH1
🧬
Gene-Disease Validity (ClinGen)
KCNH1 associated disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.55) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
16 Pathogenic / Likely Pathogenic· 255 VUS of 587 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.39LOEUF
pLI 0.546
Z-score 4.45
OE 0.21 (0.130.39)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
3.82Z-score
OE missense 0.55 (0.500.61)
317 obs / 574.3 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.21 (0.130.39)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.55 (0.500.61)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.99
01.21.6
LoF obs/exp: 8 / 37.3Missense obs/exp: 317 / 574.3Syn Z: 0.14

ClinVar Variant Classifications

587 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic8
VUS255
Likely Benign268
Benign29
Conflicting19
8
Pathogenic
8
Likely Pathogenic
255
VUS
268
Likely Benign
29
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
6
0
8
Likely Pathogenic
0
8
0
0
8
VUS
12
219
23
1
255
Likely Benign
1
27
81
159
268
Benign
0
10
12
7
29
Conflicting
19
Total13266122167587

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KCNH1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

KCNH1-related Temple-Baraitser syndrome

strong
ADGain Of FunctionAltered Gene Product Structure
Dev. DisordersSkin
G2P ↗

KCNH1-related Zimmermann-Laband syndrome

strong
ADUndeterminedAltered Gene Product Structure
Skin
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Temple-Baraitser syndrome

MIM #611816

Molecular basis of disorder known

Autosomal dominant

Zimmermann-Laband syndrome 1

MIM #135500

Molecular basis of disorder known

Autosomal dominant
📖
GeneReview available — KCNH1
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
ATP6V1B2-related epileptic encephalopathy.
Inuzuka LM et al.·Epileptic Disord
2020Case report
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →